|
Marín F, Roldán V. Biomarkers: GDF-15 and risk stratification in atrial fibrillation. Nat Rev Cardiol. 2015 Jan;12(1):8-9. doi: 10.1038/nrcardio.2014.190. Review. PubMed PMID: 25421166.
AÑO: 2015; IF: 49.421
|
25421166
|
Roldán V, Cancio S, Gálvez J, Valdés M, Vicente V, Marín F, Lip GY. The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study. Am J Med. 2015 Nov;128(11):1237-43. doi: 10.1016/j.amjmed.2015.05.036. PubMed PMID: 26087049.
AÑO: 2015; IF: 5.61
|
|
Roldán V, Vílchez JA, Manzano-Fernández S, Jover E, Gálvez J, Puche CM, Valdés M, Vicente V, Lip GY, Marín F. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation. Stroke. 2014 Mar;45(3):696-701. doi: 10.1161/STROKEAHA.113.003338. PubMed PMID: 24519407.
AÑO: 2014; IF: 5.761
|
|
Gallego P, Roldán V, Lip GY. Novel oral anticoagulants in cardiovascular disease. J Cardiovasc Pharmacol Ther. 2014 Jan;19(1):34-44. doi: 10.1177/1074248413501392. Review. PubMed PMID: 24038020.
AÑO: 2014; IF: 2.094
|
|
Vílchez JA, Roldán V, Hernández-Romero D, Valdés M, Lip GY, Marín F. Biomarkers in atrial fibrillation: an overview. Int J Clin Pract. 2014 Apr;68(4):434-43. doi: 10.1111/ijcp.12304. Review. PubMed PMID: 24372915.
AÑO: 2014; IF: 2.566
|